BioCentury | Oct 15, 2020
Finance

Larger stakes, more newcos as Canaan moves to bump up biopharma investments with new $800M fund

...of talent,” she said. Recent Canaan-built newcos include Nocion Therapeutics Inc....
BioCentury | Sep 2, 2020
Management Tracks

Namouni to lead Blueprint R&D; plus Davar to head R&D at Acadia, Napolitano replaces Burow on Vir’s board, and more

...Homeland Security under President Barack Obama, and most recently, as president of the University of California.Nocion Therapeutics Inc....
...been the health policy research organization’s CSO and EVP for the past 10 years. BC Staff Acadia Pharmaceuticals Inc. Nocion Therapeutics Inc. Indapta...
BioCentury | Dec 14, 2019
Company News

Management Tracks: Alector hires new president, COO and appoints R&D committee co-chairs; plus Pyxis, Translate Bio, Canaan, PMV, Janpix, Kiadis and more

...newly created position. Canaan promoted Julie Grant to general partner. Grant's portfolio includes pain company Nocion Therapeutics Inc....
BioCentury | Apr 19, 2019
Company News

Emerging company roundup: Kintai, Nocion, Arrakis and more

...is led by CEO Paul-Peter Tak (see “Kintai’s Host-targeting Niche in Flagship Microbiome Ecosystem” ). Nocion Therapeutics Inc....
...identify therapeutic antibodies (see “Phenotypic Screening for Antibody Discovery” ). BC Staff Arrakis Therapeutics Inc. insitro Inc. Kintai Therapeutics Inc. Nocion Therapeutics Inc. Obsidian...
BioCentury | Apr 17, 2019
Financial News

Canaan, F-Prime back pain play Nocion with $27M round

...develop non-addictive analgesics that avoid the numbness and paralysis of sodium channel blockers like lidocaine. Nocion Therapeutics Inc....
BioCentury | Apr 17, 2019
Emerging Company Profile

Nocion: Targeting pain neurons and nothing else

...believes its compounds have greater potency than has been observed for Nav1.7 blockers. COMPANY PROFILE Nocion Therapeutics Inc....
...and Women's Hospital, Boston, Mass. Harvard Medical School, Boston, Mass. Massachusetts General Hospital, Boston, Mass. Nocion Therapeutics Inc....
...voltage-gated channel α subunit 9 Karen Tkach Tuzman, Associate Editor Sodium voltage-gated channel alpha subunit 9 (Nav1.7) (SCNA9) Pain Itch Cough Nocion Nocion Therapeutics Inc....
Items per page:
1 - 6 of 6
BioCentury | Oct 15, 2020
Finance

Larger stakes, more newcos as Canaan moves to bump up biopharma investments with new $800M fund

...of talent,” she said. Recent Canaan-built newcos include Nocion Therapeutics Inc....
BioCentury | Sep 2, 2020
Management Tracks

Namouni to lead Blueprint R&D; plus Davar to head R&D at Acadia, Napolitano replaces Burow on Vir’s board, and more

...Homeland Security under President Barack Obama, and most recently, as president of the University of California.Nocion Therapeutics Inc....
...been the health policy research organization’s CSO and EVP for the past 10 years. BC Staff Acadia Pharmaceuticals Inc. Nocion Therapeutics Inc. Indapta...
BioCentury | Dec 14, 2019
Company News

Management Tracks: Alector hires new president, COO and appoints R&D committee co-chairs; plus Pyxis, Translate Bio, Canaan, PMV, Janpix, Kiadis and more

...newly created position. Canaan promoted Julie Grant to general partner. Grant's portfolio includes pain company Nocion Therapeutics Inc....
BioCentury | Apr 19, 2019
Company News

Emerging company roundup: Kintai, Nocion, Arrakis and more

...is led by CEO Paul-Peter Tak (see “Kintai’s Host-targeting Niche in Flagship Microbiome Ecosystem” ). Nocion Therapeutics Inc....
...identify therapeutic antibodies (see “Phenotypic Screening for Antibody Discovery” ). BC Staff Arrakis Therapeutics Inc. insitro Inc. Kintai Therapeutics Inc. Nocion Therapeutics Inc. Obsidian...
BioCentury | Apr 17, 2019
Financial News

Canaan, F-Prime back pain play Nocion with $27M round

...develop non-addictive analgesics that avoid the numbness and paralysis of sodium channel blockers like lidocaine. Nocion Therapeutics Inc....
BioCentury | Apr 17, 2019
Emerging Company Profile

Nocion: Targeting pain neurons and nothing else

...believes its compounds have greater potency than has been observed for Nav1.7 blockers. COMPANY PROFILE Nocion Therapeutics Inc....
...and Women's Hospital, Boston, Mass. Harvard Medical School, Boston, Mass. Massachusetts General Hospital, Boston, Mass. Nocion Therapeutics Inc....
...voltage-gated channel α subunit 9 Karen Tkach Tuzman, Associate Editor Sodium voltage-gated channel alpha subunit 9 (Nav1.7) (SCNA9) Pain Itch Cough Nocion Nocion Therapeutics Inc....
Items per page:
1 - 6 of 6